APA (7th ed.) Citation

I, M., F, L., ME, R., A, C., S, P., M, J., . . . I, M. (2020). Intratumoral nanoplexed poly I: C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors. Science translational medicine, 12(565), . https://doi.org/10.1126/scitranslmed.abb0391

Chicago Style (17th ed.) Citation

I, Márquez-Rodas, et al. "Intratumoral Nanoplexed Poly I: C BO-112 in Combination with Systemic Anti-PD-1 for Patients with Anti-PD-1-refractory Tumors." Science Translational Medicine 12, no. 565 (2020). https://doi.org/10.1126/scitranslmed.abb0391.

MLA (9th ed.) Citation

I, Márquez-Rodas, et al. "Intratumoral Nanoplexed Poly I: C BO-112 in Combination with Systemic Anti-PD-1 for Patients with Anti-PD-1-refractory Tumors." Science Translational Medicine, vol. 12, no. 565, 2020, https://doi.org/10.1126/scitranslmed.abb0391.